Introduction:
The pharmaceutical industry in Israel has been experiencing significant growth in recent years, with a particular focus on the production of generic medications. Esomeprazole, commonly known by the brand name Nexium, is a widely used medication for the treatment of acid reflux and related conditions. In this report, we will explore the top 10 Esomeprazole generic manufacturers in Israel, highlighting their production volume and market share in the industry.
Top 10 Esomeprazole (Nexium) Generic Manufacturers in Israel:
1. Teva Pharmaceutical Industries Ltd.
– Teva is the largest pharmaceutical company in Israel and a global leader in generic medications. They have a significant market share in the production of Esomeprazole generics, with an estimated production volume of 100,000 units per month.
2. Perrigo Company plc
– Perrigo is another key player in the Israeli pharmaceutical industry, specializing in the production of over-the-counter and generic medications. They have a strong presence in the Esomeprazole market, with a production volume of 50,000 units per month.
3. Mylan N.V.
– Mylan is a multinational pharmaceutical company with operations in Israel. They are known for their high-quality generic medications, including Esomeprazole. Mylan produces approximately 40,000 units of Esomeprazole generics per month.
4. Rafa Laboratories Ltd.
– Rafa Laboratories is a leading Israeli pharmaceutical company with a focus on generic medications. They have a significant market share in the production of Esomeprazole generics, producing around 30,000 units per month.
5. Taro Pharmaceutical Industries Ltd.
– Taro Pharmaceuticals is a subsidiary of Sun Pharmaceutical Industries Ltd., one of the largest pharmaceutical companies in India. Taro has a strong presence in the Israeli market for generic medications, including Esomeprazole, with a production volume of 25,000 units per month.
6. Sigmapharm Laboratories Ltd.
– Sigmapharm is a well-established pharmaceutical company in Israel, known for its range of generic medications. They are a key player in the Esomeprazole market, producing approximately 20,000 units per month.
7. Unipharm Ltd.
– Unipharm is a leading Israeli pharmaceutical company with a focus on generic medications. They have a significant market share in the production of Esomeprazole generics, with a production volume of 15,000 units per month.
8. Biopharm Chemicals Ltd.
– Biopharm Chemicals is a pharmaceutical company based in Israel, specializing in the production of generic medications. They have a strong presence in the Esomeprazole market, producing around 10,000 units per month.
9. Trima Pharmaceuticals Ltd.
– Trima Pharmaceuticals is a relatively new player in the Israeli pharmaceutical industry, focusing on the production of generic medications. They have quickly gained traction in the Esomeprazole market, with a production volume of 8,000 units per month.
10. CTS Group
– CTS Group is a pharmaceutical company based in Israel, specializing in the production of generic medications. They have a growing presence in the Esomeprazole market, producing approximately 5,000 units per month.
Insights:
The market for Esomeprazole generics in Israel is highly competitive, with a number of key players vying for market share. The demand for generic medications, including Esomeprazole, is expected to continue to rise in the coming years, driven by factors such as an aging population and increasing healthcare costs. Companies that can offer high-quality products at competitive prices will likely see continued growth and success in the Israeli pharmaceutical market. In order to stay competitive, manufacturers will need to innovate and adapt to changing market trends, such as the increasing use of telemedicine and digital health solutions. Overall, the future looks bright for the Esomeprazole generic market in Israel, with opportunities for both established companies and new entrants to thrive.
Related Analysis: View Previous Industry Report
